Prehabilitation and Posttransplant Training Program in Liver Transplantation
Launched by MARIA DELS ANGELS CEBRIA I IRANZO, PT, PHD · Jan 27, 2020
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The main objective is to study the post-surgical impact (post-S) of a Prehabilitation program on candidates for liver transplantation (LT), as well as to study the effects of posttransplant training on the clinical and functional evolution of the recipients. Also this project pretends to assess the influence of functional capacity (FC) improvement on the short and long term post-S evolution of the LT candidates. This is a prospective randomized clinical trial in which three phases follow: Prehabilitation, training and follow-up. The sample will be constituted by 60 candidates for LT, random...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Indication of elective liver transplant with favorable cardiorespiratory evaluation that does not contraindicate the transplant.
- Exclusion Criteria:
- • Any orthopedic, motor, functional, neurological, cognitive or linguistic limitation that prevents the realization of the Prehabilitation program
- • Inability to perform psychometric tests
- • Esophageal varices not treated with ligature or beta-blockers
- • Varicose veins with a high risk of digestive hemorrhage
- • Hemoglobin \<80 g/l
- • Contraindication to weight loading
- • Impossibility to comply with the Prehabilitation program (hospital admission, work, geographical location)
- • Multi-organ transplantation and liver retransplantation
- • Refusal or lacks capacity to give informed consent
About Maria Dels Angels Cebria I Iranzo, Pt, Phd
Maria dels Angels Cebria i Iranzo, PT, PhD, is a distinguished clinical trial sponsor with extensive expertise in physical therapy and research methodologies. With a strong commitment to advancing healthcare through innovative clinical studies, Dr. Cebria i Iranzo leads rigorous trials focused on improving patient outcomes and enhancing therapeutic practices. Her academic background and practical experience allow her to effectively bridge the gap between clinical practice and research, ensuring that trials are designed and executed with the highest standards of scientific integrity and ethical considerations. Through her leadership, she aims to contribute significantly to the field of rehabilitation and therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Trial Officials
Maria A Cebrià i Iranzo, PT, PhD
Principal Investigator
Hospital Universitari i Politècnic La Fe, Valencia
David Calatayud Mizrahi, MD, PhD
Study Chair
Hospital Universitari i Politècnic La Fe, Valencia
Natalia Cezón Serrano, PT
Study Chair
University of Valencia
Luis Compte Torrero, MD, PhD
Study Chair
Hospital Universitari i Politècnic La Fe, Valencia
Laura Arjona Tinaut, PT
Study Chair
University of Valencia
Rafael López Andújar, MD, PhD
Study Chair
Hospital Universitari i Politècnic La Fe, Valencia
Martín Prieto Castillo, MD, PhD
Study Chair
Hospital Universitari i Politècnic La Fe, Valencia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials